Triptolide inhibits proliferation and induces apoptosis of human melanoma A375 cells

Area of Science:

• Pharmacology
• Molecular Biology
• Cancer Research

Background:

• Triptolide, a compound from Tripterygium wilfordii, shows promise for anti-cancer applications.
• Human melanoma A375 cells are a relevant model for studying anti-tumorigenic effects.

Purpose of the Study:

• To investigate the anti-proliferative and pro-apoptotic effects of triptolide on human melanoma A375 cells.
• To elucidate the molecular mechanisms underlying triptolide's action, including cell cycle arrest and apoptosis pathways.

Main Methods:

• Cell Counting Kit 8 (CCK8) assay for proliferation assessment.
• Hoechst 33258 staining and flow cytometry for apoptosis analysis.
• Caspase assays and Western blotting to examine signaling pathways (NF-κB, Bcl-2, Bcl-XL).

Main Results:

• Triptolide significantly inhibited proliferation and induced apoptosis in A375 cells.
• Triptolide caused S-phase arrest and activated caspase-dependent intrinsic apoptotic pathways.
• Down-regulation of NF-κB (p65), Bcl-2, and Bcl-XL expression was observed.

Conclusions:

• Triptolide demonstrates potent anti-proliferative and pro-apoptotic activities against human melanoma A375 cells.
• The anti-cancer effects are mediated via caspase activation and NF-κB pathway inhibition.
• Triptolide represents a potential therapeutic agent for melanoma treatment.